LANTHEUS HOLDINGS INC. - COMMON STOCK

100,85

12-марта-25 16:45:01

15 мин. задержка

Акции

-3,77

-3,60%

Сегодняшний диапазон

97,77 - 105,67

ISIN

N/A

Источник

NASDAQ

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

26 фев 2025 07:00:01 Источник Nasdaq GlobeNewswire
Lantheus to Present at Upcoming Investor Conferences

21 фев 2025 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

12 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

05 фев 2025 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

30 янв 2025 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

28 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market

13 янв 2025 00:05:00 Источник Nasdaq GlobeNewswire
Lantheus to Present at the Jefferies London Healthcare Conference

13 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

11 ноя 2024 07:39:54 Источник Nasdaq GlobeNewswire
Lantheus Reports Third Quarter 2024 Financial Results

06 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

04 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

23 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

15 сен 2024 08:45:00 Источник Nasdaq GlobeNewswire
Lantheus Appoints Julie Eastland as New Board Member

05 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

28 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

20 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
Lantheus Reports Second Quarter 2024 Financial Results

31 июл 2024 07:00:01 Источник Nasdaq GlobeNewswire
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time

17 июл 2024 08:30:00 Источник Nasdaq GlobeNewswire
NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

16 июл 2024 09:45:06 Источник NetDania Notify
NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

15 июл 2024 09:54:58 Источник NetDania Notify

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.